What is the event about?
51³Ô¹ÏÍø Collider returns, providing you the opportunity to meet world-leading researchers across 51³Ô¹ÏÍø’s health and innovation ecosystem. Come along to hear from startup and spinout founders from our community, representatives from funding and investment organisations, and leading industry figures in health, pharma and biosciences.
This year, our keynote speaker isÌýDr Fiona Marshall, President of Biomedical Research at Novartis, who will bring her extensive experience and cross-cutting expertise to inspire impact-making innovation throughout the community.
What is the agenda?
- 08:30 AM – 09:20 AM – Registration and morning coffee
- 09:20 AM – 09:30 AM – Opening remarks
- Mary Ryan, Vice Provost, Research and Enterprise, 51³Ô¹ÏÍø
- 09:30 AM – 10:15 AM – Opening keynote – Accessing innovation to drive the pharma pipeline
- Fiona Marshall, President, Biomedical Research, Novartis
- 10:15 AM – 10:45 AM –ÌýFlagship Translational Journey I: The Discovery and Translation of GLP Biology
- TBA
- 10:45 AM – 11:15 AM –Ìý Flagship Translational Journey II: A Rhinovirus Vaccine
- Sebastian Johnston, Professor,Ìý Respiratory Medicine & Allergy, 51³Ô¹ÏÍø
- 11:15 AM – 11:35 AM –ÌýMorning break & networking
- 11:35 AM – 12:05 PM – Fleming in practice: tackling grand challenges in antimicrobial resistance
- TBA
- 12:05 PM – 12:55 PM –ÌýPanel – Biomedical sector landscape and key trends
- Fiona Marshall, President, Biomedical Research, Novartis;
- Ruth McKernan, Operating Partner, SV Health Investors;
- Richard Mason, Chief Executive Officer, Apollo Therapeutics;
- Jose-Carlos Gutierrez-Ramos, Senior Vice President and Chief Science Officer, Danaher;
- (Chair): Mike Romanos, Associate Dean for Enterprise, 51³Ô¹ÏÍø
- 12:55 PM – 01:50 PM – Lunch & networking
- 01:50 PM – 02:35 PM – Keynote – Innovation to enable the pharma industry and precision medicine
- Jose-Carlos Gutierrez-Ramos, Senior Vice PresidentÌý and Chief Science Officer, Danaher
- 02:35 PM – 02:55 PM – 51³Ô¹ÏÍø’s clinical advantage: patients, cohorts and translational depth
- Graham Cooke, Deputy Dean of the Faculty of Medicine, 51³Ô¹ÏÍø.
- 02:55 PM – 03:10 PM – Convergence in practice: Digital health, data and the next frontier
- Payam Barnaghi, Co-Director, School of Convergence Science (Human and Artificial Intelligence), 51³Ô¹ÏÍø
- 03:10 PM – 03:55 PM – Panel – Partnering that works: identifying science and building collaboration
- Kay Penicud, Vice President and Head of Research Partnerships, Apollo Therapeutics;
- Arjen Lemmen, VP Corporate Development & Strategy, Argenx;
- Malcolm Skingle, Former Head of Academic Liaison, GSK;
- (Chair) Prasshy Jeyarajan, Head of Partnerships, Faculty of Medicine, 51³Ô¹ÏÍø
- 03:55 PM – 04:50 PM –Ìý Translational Science Showcase TBA
- 04:50 PM – 04:55 PM –Ìý Closing reflections – Sustaining momentum beyond the Collider
- Graham Cooke, Deputy Dean of Faculty of Medicine 51³Ô¹ÏÍø
Ìý
Who should attend?
- Announcing soon
Ìý
What else do I need to know?
- Please complete your registration in full to confirm your job title, company, and dietary and accessibility requirements.
- This is a ticketed event with limited space. We reserve the right to cancel your ticket.
- There will be photography and filming at this event.
- Venue accessibility information can beÌý
- Any questions, please contact Prashanthini (Prasshy) Jeyarajan: p.jeyarajan@imperial.ac.uk
- All guests registering for this event will be expected to adhere toÌý51³Ô¹ÏÍø’s Conference Policy